Effect of Formula on Growth of Infants From Overweight or Obese Mothers

Sponsor
Nestlé (Industry)
Overall Status
Completed
CT.gov ID
NCT00820833
Collaborator
(none)
230
1
3
86
2.7

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether infants, from overweight or obese mothers, fed a formula with proteins and calories different than a standard infant formula have a different growth

Condition or Disease Intervention/Treatment Phase
  • Other: standard infant formula
  • Other: Test formula
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
230 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Official Title:
Effect of Protein Levels and Caloric Density on the Growth of Formula Fed Infants From Overweight or Obese Mothers
Study Start Date :
Oct 1, 2007
Actual Primary Completion Date :
Jun 1, 2010
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: 1

Standard infant formula

Other: standard infant formula
standard infant formula given from 3 to 12 months of age, as per standard requirement

Experimental: 2

Test formula

Other: Test formula
Test formula with different protein and calorie content than standard formula, given from 3 to 12 months of age. As per standard requirement.

No Intervention: 3

Breastfeeding reference group

Outcome Measures

Primary Outcome Measures

  1. mean weight gain [3 months]

Secondary Outcome Measures

  1. blood test assessments; body composition, bone density [9 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 12 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy newborn infant

  • birth weight between 2500g and 4800g

  • singleton birth

  • mother's BMI before pregnancy was between 26 and 25

  • for the breastfeeding group: mother has elected to exclusively breastfeed her baby from birth to at least 6 months of age

  • for the formula groups: mother has elected to exclusively formula feed her baby from 3 to 6 months of age

  • having obtained signed informed consent of legal representative

Exclusion Criteria:
  • body weight smaller than 5th percentile for that gestational age

  • newborn whose mother has diabetes

  • newborn whose mother has a drug dependence during pregnancy

  • newborn currently participating in another trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 Departamento de Medicina Interna, University de la Frontera Temuco Chile

Sponsors and Collaborators

  • Nestlé

Investigators

  • Principal Investigator: Jaime Inostroza, PhD, Universidad de La Frontera

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nestlé
ClinicalTrials.gov Identifier:
NCT00820833
Other Study ID Numbers:
  • 05.29.INF
First Posted:
Jan 12, 2009
Last Update Posted:
Mar 26, 2015
Last Verified:
Dec 1, 2014
Keywords provided by Nestlé
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 26, 2015